Yuanta S&P 500 ETF (00646)

Overview

Voxel S.A., established in 2005 and headquartered in Kraków, Poland, is a prominent player in the field of diagnostic imaging laboratories within the region. The company’s operations span across multiple segments, including Diagnostics, Therapy, and Information Technology. Voxel S.A. focuses on delivering comprehensive diagnostic imaging services, leveraging advanced technologies and methodologies to meet the diverse needs of its clientele. Through its network of facilities, the company provides critical diagnostic and therapeutic services, alongside engaging in nuclear medicine research and the development of innovative healthcare solutions.

Products and Services

• Diagnostic Imaging Services - Voxel S.A. offers a wide array of imaging services such as magnetic resonance imaging (MRI) scans, computed tomography (CT) scans, and positron emission tomography (PET). These services play a crucial role in the accurate diagnosis of various conditions, aiding healthcare professionals in devising effective treatment plans.
• Teleradiology Services - The company extends its diagnostic capabilities through teleradiology, allowing for the transmission of radiological patient images from one location to another. This service facilitates remote diagnoses, making medical expertise accessible across different geographies.
• Neuroradiosurgery Services - Specializing in neuroradiosurgery, Voxel S.A. employs precision-targeted therapeutic interventions for treating neurological conditions. This approach minimizes invasiveness while maximizing treatment effectiveness.
• Nuclear Medicine Research - Engaging in cutting-edge nuclear medicine research, Voxel S.A. explores new frontiers in diagnostics and therapy, contributing to advancements in medical science and patient care.
• Neurological Hospitals and COVID-19 Diagnostics - The company runs neurological hospitals offering specialized care, alongside laboratories dedicated to COVID-19 diagnostics. These facilities ensure patients receive timely and accurate testing and treatment for a wide range of conditions, including infectious diseases.
• Information Systems for Hospitals - Voxel S.A. develops and implements comprehensive information systems for hospitals, streamlining operations, enhancing patient care, and facilitating the efficient management of healthcare data.
• Clinical Test Services - Offering clinical test services, the company supports the healthcare industry with essential diagnostic testing, aiding in the early detection and management of diseases.
• Radiopharmaceuticals - Voxel S.A. is involved in the production and sale of radiopharmaceutical products, which are critical in the field of nuclear medicine for diagnostics and therapy. These products play a key role in a range of medical procedures, from cancer treatment to heart disease diagnosis.